新易盛(300502) - 2023 Q3 - 季度财报
EOPTOLINKEOPTOLINK(SZ:300502)2023-10-20 16:00

Financial Performance - The company's revenue for Q3 2023 was ¥782,363,726.80, a decrease of 16.38% compared to the same period last year, which reported ¥935,659,156.54[4] - Net profit attributable to shareholders for Q3 2023 was ¥141,198,619.60, down 53.14% from ¥301,347,356.04 in the previous year[4] - Total operating revenue for Q3 2023 was ¥2,087,047,551.82, a decrease of 13.5% compared to ¥2,414,507,112.66 in Q3 2022[13] - Net profit for Q3 2023 was ¥429,563,503.52, a decline of 43.6% from ¥762,434,251.88 in Q3 2022[14] - The total comprehensive income for Q3 2023 was ¥432,445,766.41, down from ¥763,915,850.62 in Q3 2022, a decline of 43.3%[15] Earnings and Shareholder Information - Basic earnings per share for Q3 2023 were ¥0.20, a decline of 52.38% from ¥0.42 in the previous year[4] - Basic earnings per share for Q3 2023 were ¥0.61, compared to ¥1.07 in Q3 2022[15] - The total number of common shareholders at the end of the reporting period is 87,414, with the top ten shareholders holding a combined 7.39% to 0.68% of shares[9] - The company has a significant shareholder, LO JEFFREY CHIH, holding 3.77% of shares, equivalent to 26,789,548 shares[9] Assets and Liabilities - Total assets as of September 30, 2023, were ¥6,081,888,071.47, reflecting a 3.50% increase from ¥5,876,061,496.29 at the end of the previous year[4] - Total liabilities decreased to ¥878,127,408.30 in Q3 2023 from ¥1,046,893,880.44 in Q3 2022, reflecting a reduction of 16.1%[13] - The total assets increased to ¥6,081,888,071.47 in Q3 2023 from ¥5,876,061,496.29 in Q3 2022, reflecting a growth of 3.5%[13] Cash Flow - The net cash flow from operating activities increased by 114.28% to ¥877,084,107.62, compared to ¥409,309,294.40 in the same period last year[8] - Total cash inflow from operating activities is ¥2,395,911,318.24, down 13.6% from ¥2,773,987,502.08 in the previous period[16] - Cash outflow from operating activities totals ¥1,518,827,210.62, a decrease of 35.8% compared to ¥2,364,678,207.68 in the previous period[17] - The net increase in cash and cash equivalents for the current period is ¥613,828,573.86, compared to an increase of ¥64,147,858.04 in the previous period[17] Investment and Expenses - The company experienced a 95.83% decrease in investment income, reporting ¥4,346,586.25 compared to ¥104,331,040.25 in the previous year[8] - Research and development expenses for Q3 2023 were ¥100,283,222.99, down from ¥111,436,020.83 in Q3 2022, a decrease of 10.0%[14] - The company’s financial expenses decreased by 33.61% to -¥105,424,831.25, primarily due to a decline in exchange gains[8] Inventory and Receivables - Accounts receivable decreased from ¥661,963,107.43 to ¥563,809,273.33, reflecting a reduction of approximately 14.85%[12] - Inventory decreased from ¥1,469,203,587.93 to ¥1,061,364,562.84, indicating a decline of about 27.8%[12]

EOPTOLINK-新易盛(300502) - 2023 Q3 - 季度财报 - Reportify